Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Camanni

Showing results (221-230 of 228) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 228 results.
Journal of Endocrinological Investigation|June 15, 2005
Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary diseaseG Aimaretti, G Corneli, C Di Somma, et al.
Journal of Endocrinological Investigation|April 9, 2002
Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center studyM Gasperi, E Martino, L Manetti, et al.
Journal of Endocrinological Investigation|June 24, 2006
Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 2002-2004: Data from the GH RegistryG Migliaretti, G Aimaretti, A Borraccino, et al.
Clinical Endocrinology|September 1, 1999
Comparison of six months therapy with octreotide versus lanreotide in acromegalic patients: a retrospective studyP Razzore, A Colao, R Baldelli, et al.
Minerva Endocrinologica|August 23, 2000
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarismM Procopio, M Maccario, P Savio, et al.
Panminerva Medica|May 9, 1998
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarismM Procopio, M Maccario, P Savio, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg)R Baldelli, A Colao, P Razzore, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormoneE Arvat, M Maccario, L Di Vito, et al.
Pageof 23

Showing results (221-230 of 228) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
Journal of Endocrinological Investigation|June 15, 2005
Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary diseaseG Aimaretti, G Corneli, C Di Somma, et al.
Journal of Endocrinological Investigation|April 9, 2002
Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center studyM Gasperi, E Martino, L Manetti, et al.
Journal of Endocrinological Investigation|June 24, 2006
Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 2002-2004: Data from the GH RegistryG Migliaretti, G Aimaretti, A Borraccino, et al.
Clinical Endocrinology|September 1, 1999
Comparison of six months therapy with octreotide versus lanreotide in acromegalic patients: a retrospective studyP Razzore, A Colao, R Baldelli, et al.
Minerva Endocrinologica|August 23, 2000
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarismM Procopio, M Maccario, P Savio, et al.
Panminerva Medica|May 9, 1998
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarismM Procopio, M Maccario, P Savio, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg)R Baldelli, A Colao, P Razzore, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormoneE Arvat, M Maccario, L Di Vito, et al.
Pageof 23